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Abstract Dun1p and Rad53p of the budding yeast Sacchar-
omyces cerevisiae are members of a conserved family of cell cycle
checkpoint protein kinases that contain forkhead-associated
(FHA) domains. Here, we demonstrate that these FHA domains
contain 130^140 residues, and are thus considerably larger than
previously predicted by sequence comparisons (55^75 residues).
In vivo, expression of the proteolytically defined Dun1p FHA
domain, but not a fragment containing only the predicted domain
boundaries, inhibited the transcriptional induction of repair genes
following replication blocks. This indicates that the non-catalytic
FHA domain plays an important role in the transcriptional
function of the Dun1p protein kinase.
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1. Introduction
Cell cycle checkpoints play an essential role in maintaining
the integrity of the genome by delaying the progression
through the cell cycle in response to DNA damage, replication
blocks or mitotic spindle assembly defects [1]. The importance
of such surveillance mechanisms is underscored by the exis-
tence of human genetic disorders with impaired checkpoint
functions, such as ataxia^telangiectasia (AT), Nijmegen
breakage syndrome and Li^Fraumeni syndrome, resulting in
a predisposition to cancer [2,3]. As might be expected for a
cellular event of such fundamental importance, checkpoint
signalling pathways are highly conserved at the molecular
level from budding yeast (Saccharomyces cerevisiae) and ¢s-
sion yeast (Schizosaccharomyces pombe) through nematodes
and £ies to humans [1,4,5].
The S. cerevisiae checkpoint proteins Dun1p [6] and
Rad53p [7] are members of a conserved family of forkhead-
associated (FHA) domain-containing protein kinases that in-
cludes Cds1 in S. pombe, and Chk2/Cds1 in mammals [8^10].
These kinases are activated by phosphorylation in response to
checkpoint signals, and the activation depends on the ATM
protein kinase [9,10], that is mutated in AT patients, or its
homologues Mec1p (S. cerevisiae) [11,12] and Rad3 (S.
pombe) [13], respectively. Mutations in these kinases cause a
failure of cell cycle checkpoints, resulting in reduced viability
following DNA damage or replication blocks in yeast, and,
importantly, are the cause of a subset of human patients with
the Li^Fraumeni multicancer syndrome [3].
FHA domain-containing kinases have also been identi¢ed
in Drosophila and Caenorhabditis elegans, and S. cerevisiae
contains a third such kinase, Mek1p, that is involved in the
regulation of meiosis [14]. All these kinases contain a single
FHA domain in their N-terminus, except for Rad53p which
has another FHA domain in the C-terminus. However, mod-
ular FHA domains are not restricted to protein kinases, and
are found in more than 120 diverse proteins (see http:
//smart.embl-heidelberg.de). Based on sequence comparisons,
the FHA domain was predicted to contain 55^75 amino acid
residues [15]. To date, little is known about the function of
FHA domains, but the available data indicate that FHA do-
mains act as protein^protein interaction modules, possibly in
a phosphorylation-dependent manner. For example, the
C-terminal FHA domain (FHA2) of Rad53p can directly in-
teract with Rad9p, but only when the latter is phosphorylated
[16] ; likewise, the FHA domain of a plant kinase-associated
protein phosphatase (KAPP) binds only to the phosphorylat-
ed form of a receptor-like protein kinase [17]; and ¢nally, it
has recently been shown that FHA domains can directly bind
to phosphothreonine-containing peptides in vitro [18], remi-
niscent of SH2 domain interactions with phosphotyrosine res-
idues.
As little is known about the structure and functional spe-
ci¢city of FHA domains in general, we characterized the
N-terminal FHA domains of Rad53p and Dun1p. The data
presented here indicate that FHA domains are considerably
larger than apparent from sequence comparisons, and that the
Dun1-FHA domain plays a role in the transcriptional re-
sponse to replication blocks.
2. Materials and methods
2.1. Generation of FHA domain constructs
FHA domain constructs were generated by polymerase chain reac-
tion (PCR) using synthetic oligonucleotides (Dun1(1^184)forward, 5P-
ATG AAT TCA TGA GTT TGT CCA CGA AAA G-3P ; Dun1(1^
184)reverse, 5P-GCT CTA GAT TAG TGA TGG TGA TGG TGA
TGT GCG GCA CTC GTT GTA GC-3P ; Dun1(19^159)forward, 5P-
GAT CGA ATT CAA AAG ACA GCA ACG AAG-3P ; Dun1(19^
159)reverse, 5P-GAT CGT CGA CTT AAT ATG AAC GAC TTT
CTG-3P ; Dun1(56^112)forward, 5P-GAT CGA ATT CAC TAC AAT
CGG TAG AAG-3P ; Dun1(56^112)reverse, 5P-GAT CGT CGA CTT
ACA AAC GAT TAC CAT TAA TAA AAG-3P ; Rad53(1^199)for-
ward, 5P-CAA CTA ACC ATG GAA AAT ATT ACA CAA C-3P ;
Rad53(1^199)reverse, 5P-CTT GTT GGA TCC CAT TGA TGA
TGC AGT AGA TG-3P ; cloning sites are underlined) and the Expand
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High Fidelity DNA polymerase mixture (Roche). Dun1 constructs
were generated using the yeast DUN1 cDNA [6] as template, Rad53
constructs were generated by PCR using random hexamer primed
cDNA synthesized from poly(A)-RNA of the yeast strain AB1380
[MATa, ura3-52, lys2-l, ade2-l, his5, trp1, can1-100, Ile3, Thr3]. For
bacterial expression, cDNAs were cloned into pQE60 (Qiagen) be-
tween the NcoI and the BamHI or HindIII sites, respectively. For
yeast expression, constructs were ligated to the Gal4p DNA binding
domain for nuclear targetting by initial cloning into pGBT9 (Clon-
tech) followed by ligation of the resulting HindIII^SalI restriction
fragment into the inducible vector p416Gal1 [19]. Plasmids were trans-
formed into the Escherichia coli strain XL1-Blue (Stratagene) and
sequences of all PCR-generated fragments were con¢rmed by auto-
mated DNA sequence analysis using dye terminator kits (Perkin-El-
mer).
2.2. Bacterial expression, protein puri¢cation and limited proteolysis
experiments
For bacterial expression, plasmids were transformed into the E. coli
strain BL21(DE3) that was pretransformed with the pREP4 plasmid
(Qiagen) to achieve tighter control of induction. Cultures were grown
to mid-log phase in rich medium and expression was induced for 3 h
at 30‡C using 0.5 mM IPTG. Cells were lysed using Triton X-100 and
lysozyme, and soluble His6-tagged protein was puri¢ed to near homo-
geneity using Ni2 a⁄nity chromatography followed by SP-Sepharose
(Pharmacia) cation-exchange chromatography essentially as described
[20]. Puri¢ed proteins were dialyzed against 20 mM HEPES, pH 7, 1
mM DTT and concentrated to 10^20 mg/ml using Centricon mem-
branes (Amicon), snap-frozen and stored at 320‡C until use.
Proteolysis experiments were performed at room temperature using
1 mg/ml Dun1(1^184), Rad53(1^199) and Rad53(547^729), respec-
tively, and 10 Wg/ml of the endopeptidase (Roche) indicated in the
¢gure legends and Table 1. 10 Wl aliquots were removed at the times
indicated and the reaction was terminated by immediately boiling the
samples in sodium dodecyl sulfate^polyacrylamide gel electrophoresis
(SDS^PAGE) loading bu¡er. Reaction products were separated in
15% SDS^polyacrylamide gels and visualized by Coomassie brilliant
blue R250 (Bio-Rad) staining.
2.3. Protein sequencing and mass spectrometry
For N-terminal sequencing, aliquots of the proteolysis experiments
were transferred onto polyvinyldi£uoride membranes after SDS^
PAGE and stained with Ponceau-S. Bands corresponding to the pro-
tease-resistant fragments were excised and sequenced with a Hewlett
Packard G1000A Protein Sequencer as described [21]. Protease-resist-
ant fragments were puri¢ed by chromatography on a Brownlee Aqua-
pore RP300 column (300 Aî , 7 Wm, C8, 250U2.1 mm) using an ace-
tonitrile gradient in tri£uoroacetic acid, identi¢ed by SDS^PAGE and
subjected to mass analysis using a PerSeptive Biosystems Voyager DE
mass spectrometer (MALDI-TOF) or a Perkin-Elmer Sciex API III
triple quadrupole mass spectrometer (ES-MS) as described [21].
2.4. Yeast cultures, RNA preparation and Northern blot experiments
All experiments were performed in the K699 strain [MATa, ade2-1,
trp1-1, leu2-3,112, his3-11,15, ura3, can1-100]. Yeasts were trans-
formed with p416Gal1 constructs using lithium acetate/polyethylene-
glycol 3350, and selected on synthetic medium lacking uracil. Before
experiments, overnight cultures in selective medium containing 2%
sucrose were diluted to OD600 = 0.1 and grown for 6 h at 30‡C in
selective medium containing 2% sucrose and 4% galactose to induce
expression of Gal4^FHA fusion proteins, followed by addition of
hydroxyurea (HU). Total RNA was prepared by resuspending yeast
pellets from 10 ml cultures in 300 Wl 0.5 M NaCl, 200 mM Tris^HCl,
pH 7.4, 10 mM EDTA and vigorous vortexing after addition of 300 Wl
phenol and 300 Wl glass beads, extraction of the supernatant with
CHCl3/isoamylalcohol (24:1) and precipitation with three volumes
ethanol. For Northern blot analysis, 20 Wg total RNA was loaded
per lane after denaturation with formamide/formaldehyde and elec-
trophoresed in 1.2% agarose gels containing formaldehyde, followed
by capillary transfer onto Hybond-N membranes (Amersham) using
standard procedures. A probe speci¢c for the RNR2 mRNA was
generated by PCR from random-primed yeast cDNA using synthetic
oligonucleotides (RNR2forward, 5P-TAC CAT GAA ATC TGG
CAG C-3P ; RNR2reverse, 5P-TTG AAG AGA CTG CGT AAA
AAG-3P). This probe was cloned into pGEM-T (Promega) and con-
¢rmed by automated sequencing as above. As a control, membranes
were rehybridized using an 18S RNA antisense oligonucleotide (5P-
GCT TAT ACT TAG ACA TGC AT-3P). After high-stringency
washes, RNA blots were quanti¢ed by phosphorimaging using Image-
Quant software (Molecular Dynamics).
3. Results
3.1. Determination of FHA domain boundaries using limited
proteolysis
The currently known FHA domains share overall less than
25% sequence identity in a region of 55^75 amino acid resi-
dues with only four residues comprising an over 80% consen-
sus, and three further residues comprising the over 65% con-
sensus sequence (http://smart.embl-heidelberg.de). As the
prediction of the boundaries of such highly diverse domains
by sequence comparisons may miss residues £anking the do-
main core, we chose to experimentally determine FHA do-
main boundaries by using a limited proteolysis approach.
This approach is based on the assumption that under native
conditions, proteases preferentially cleave freely accessible
peptide bonds, but do not cut near residues that are inacces-
sible as part of compact domain structures. To identify the
boundaries of the FHA domain of the yeast Dun1p protein
kinase, a recombinant fragment containing the entire N-ter-
minal region of Dun1p preceding its catalytic domain
(Dun1(1^184)) was incubated with chymotrypsin, a protease
that cleaves C-terminal of bulky hydrophobic residues. Anal-
ysis of reaction products by SDS^PAGE revealed that, within
2 min, this fragment was quantitatively converted to a V16
kDa fragment that was then remarkably stable over the
course of the 1 h experiment (Fig. 1A). Similar results were
also obtained from the digest of the Dun1(1^184) fragment
using endopeptidase Glu-C, that cleaves C-terminal of gluta-
mic acid residues (Fig. 1B). The subsequent analysis of these
protease-resistant fragments by N-terminal sequence analysis
and mass spectrometry (Table 1) revealed them to contain
residues 19^159 (chymotrypsin) and 9^155 (endopeptidase
Glu-C). This experiment indicated that the Dun1p FHA do-
main contains approximately 137 residues from Lys-19 to
Glu-155, and that it is thus considerably larger than the 57
residue motif ¢rst identi¢ed by sequence alignments (Val-56^
Leu-112).
To independently con¢rm that FHA domains are indeed
twice as large as previously thought, similar experiments
were performed for the Rad53p FHA1 domain. A recombi-
nant fragment (Rad53(1^199)) containing the entire N-termi-
nal region preceding the protein kinase catalytic domain was
puri¢ed and incubated with chymotrypsin (Fig. 2A) and
endopeptidase Glu-C (Fig. 2B), respectively. In both experi-
ments, the Rad53(1^199) fragment was converted to protease-
resistant fragments similar to those in the corresponding ex-
periments with the Dun1p N-terminus (Fig. 1). However, in
both cases, the predominant protected bands were generated
on a slower time-scale than for Dun1(1^184). Particularly in
the case of the endopeptidase Glu-C digest, two reaction in-
termediates persisted to some extent over the 3 h experiment,
indicating that the £anking sequences may interact with the
Rad53-FHA1 domain. Nevertheless, the band that accumu-
lated most noticeably during the experiment (indicated by the
arrow in Fig. 2B) had an electrophoretic mobility similar to
the protected bands in the other three experiments (Figs. 1A,B
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and 2A). N-terminal sequencing and mass spectrometry dem-
onstrated that the protease-resistant fragments encompassing
the Rad53-FHA1 domain corresponded to residues 24^167
(chymotrypsin) and 22^156 (endopeptidase Glu-C), respec-
tively (Table 1), indicating that this domain contains approx-
imately 133 residues located between Ser-24 and Glu-156.
The domain boundaries determined here for the Dun1-
FHA and Rad53-FHA1 domains have a size similar to the
part of Rad53p (residues 547^729) encompassing the FHA2
domain that was found to interact with Rad9p in yeast two-
hybrid assays [16]. Therefore, we also produced a Rad53(547^
729) fragment for proteolytic analysis. Digestion of this pro-
tein with a variety of proteases produced protected fragments
with just slightly faster mobility than the undigested protein
(data not shown). Sequencing of the chymotrypsin-generated
fragment revealed His-559 as its N-terminal residue, but as the
products of three di¡erent enzymes did not yield results in the
mass spectrometric analysis (Table 1), the C-terminus of the
Rad53-FHA2 domain could not be assigned.
The alignment of the sequences in Fig. 3 shows that the
proteolytic cleavage sites determined here are located in close
proximity to each other, indicating similar domain boundaries
for all three FHA domains. The fact that endopeptidase Glu-
C cleaves the Rad53-FHA1 domain at Glu-21 but not at the
nearby Glu-26 and Glu-30 residues, and its cleavage of the
Dun1-FHA domain at Glu-155 but not at Glu-150 or Glu-
146, respectively, underscores the precision of the assignment
of the FHA domain boundaries. Furthermore, Dun1p and
Rad53p each contain three protease-resistant glutamic acid
residues located between the N-terminal domain boundaries
determined here and the predicted FHA domain core, and
two (Dun1p) or three (Rad53p) protected glutamic acid resi-
Table 1
Identi¢cation of proteolytically stable FHA domains
Substrate Protease N-terminus Mass (observed) Mass (theory) Protected fragment
Dun1(1^184) Chymotrypsin KRQQRSNKPS 16 089a 16 096 19^159
Endo-Glu-C HSGDV 16 630a 16 635 9^155
Rad53(1^199) Chymotrypsin SQEQI 16 153b 16 152 24^167
Endo-Glu-C KFSQE 15 104b 15 103 22^156
Rad53(549^729) Chymotrypsin HSNNTE n.d.c 559^?
aMALDI-TOF.
bES-MS.
cProteolytically stable fragments containing the RAD53-FHA2 domain using chymotrypsin, thermolysin and trypsin did not give results in
mass spectrometric analyses.
Fig. 1. Identi¢cation of protease-resistant Dun1-FHA domain frag-
ments. Dun1(1^184) was incubated with chymotrypsin (A) or endo-
peptidase Glu-C (B) for the times (min) indicated on top. Mass
standards are indicated on the left (from top: 200, 116, 97.4, 69, 43,
31, 21, 14 and 6.5 kDa). Arrows point to the major protected frag-
ment in each experiment.
Fig. 2. Identi¢cation of protease-resistant Rad53-FHA1 domain
fragments. Chymotrypsin (A) or endopeptidase Glu-C (B) were
added for the times (min) indicated on top. Mass standards are in-
dicated on the left (from top: 200, 116, 97.4, 69, 43, 31, 21, 14 and
6.5 kDa). Arrows point to the major protected fragment in each ex-
periment. Proteolysis products that migrate as a smear at the bot-
tom of the gels are smaller than the predicted FHA domain core
and were not further characterized.
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dues between the predicted core and the assigned C-terminal
domain boundary. Likewise, there are several bulky hydro-
phobic amino acids located between these domain boundaries
and the predicted core that are not cleaved by chymotrypsin.
The fact that all these residues are protease-resistant strongly
indicates that the sequences £anking the predicted FHA do-
main core are part of a compact domain structure and not
just loosely associated with it.
3.2. Role of the Dun1-FHA domain in the transcriptional
response pathway
Dun1p is involved in the inactivation of the Crt1p tran-
scriptional repressor protein by phosphorylation in response
to checkpoint signals [22]. This results in the induction of
repair genes including RNR subunits [6]. DUN1 has additional
functions in the G2/M arrest in response to DNA damage
[23,24]. However, no direct kinase substrates nor the role of
the FHA domain in these pathways are currently known. To
analyze the role of the FHA domain in the regulation of
Dun1p, we overexpressed Dun1-FHA constructs in yeast in
vivo and tested if this could interfere with the function of the
endogenous Dun1p protein kinases by competing for either
upstream activators or downstream e¡ectors. If the FHA do-
main is involved in the transcriptional function of Dun1p, a
fragment corresponding to the proteolytically de¢ned FHA
domain boundaries should result in a reduced transcriptional
induction of repair proteins in response to replication blocks,
but a truncated construct containing only the predicted FHA
domain core should have little or no e¡ect.
Yeast strains were transformed with inducible FHA domain
constructs. Upon induction, DNA replication of these yeast
strains was blocked in mid-log phase by addition of 150 mM
HU. Aliquots of the cultures were removed for RNA prepa-
ration at time points indicated in Fig. 4A. RNA blot analysis
of the samples revealed that the Dun1(19^159) construct, but
not the Dun1(56^112) construct, caused an approximately
60% reduction in the transcriptional induction of the RNR2
mRNA in response to the HU-dependent replication block,
when compared to the vector only control (Fig. 4A). This
indicates that the FHA domain plays a crucial role in the
function of the Dun1p protein kinase and con¢rms the results
of the limited proteolysis studies. The Dun1(19^159) express-
ing yeast cells remained fully viable during the 3 h replication
block (Fig. 4B) and had normal growth properties on plates
containing methylmethanesulfonate to induce DNA damage
(data not shown). This indicates that the FHA domain did
not cause a general checkpoint defect resulting in diminished
cell survival.
4. Discussion
DUN1 has previously been shown to be involved in the
transcriptional induction of repair genes and the G2/M arrest
in response to cell cycle checkpoint signals, but the molecular
mechanisms of these functions are currently unclear. Our data
show that the FHA domain plays a crucial role in the tran-
scriptional function of the Dun1p kinase, as overexpression of
the Dun1-FHA domain reduced the transcriptional response
by 60%. The residual levels of RNR2 induction in the
Dun1(19^159) strain are similar to those elicited by an un-
characterized alternative pathway in dun1 null strains
[6,22,25]. This indicates that overexpression of the Dun1(19^
159) fragment can almost completely abolish the DUN1-de-
pendent component of the transcriptional response. However,
yeast overexpressing this FHA domain remained fully viable
under replication block (Fig. 4B) and DNA damage promot-
ing conditions (data not shown), in contrast to the checkpoint
defect observed in dun1 null strains [23,24]. Therefore, the
Fig. 3. Sequence alignment of the Dun1-FHA, Rad53-FHA1 and Rad53-FHA2 domains. The positions of cleavage sites in limited proteolysis
experiments are indicated. The FHA core domain predicted by sequence comparisons is boxed. Asterisks indicate residues that are conserved in
80% of all FHA domains, circles indicate additional residues conserved in 65% of FHA domains. Identical residues in all three sequences are
indicated by black boxes, those conserved in two sequences by gray boxes. The alignment was generated using SMART [28] and CLUSTAL-W
[29] and manually modi¢ed to improve similarity.
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Dun1-FHA domain seems to function speci¢cally in the tran-
scriptional response but not in cell cycle arrest pathways.
The data presented here indicate that FHA domains in
general are much larger than predicted by sequence compar-
isons. It was recently reported that the interaction of the plant
KAPP with receptor-like protein kinases also required some
30 additional residues on either side of its predicted FHA
domain [26]. This was interpreted as an indication that these
additional residues enhance the binding of the predicted FHA
domain by directly interacting with the target [26]. However,
our proteolysis experiments strongly suggest that additional
residues £anking the predicted FHA domain core are actually
an integral part of a compact domain structure. As the Dun1-
FHA and Rad53-FHA1 domain boundaries correspond well
with the £anking sequences required for protein^protein in-
teractions by the KAPP-FHA and Rad53-FHA2 domains
[16,26], the only other FHA domains characterized in some
molecular detail, we propose that FHA domains are consid-
erably larger (up to 140 residues) than the 55^75 residues
predicted by sequence comparisons. This proposal is sup-
ported by the nuclear magnetic resonance structure of the
Rad53-FHA2 domain [27], that was published while this
manuscript was in preparation, showing that all residues of
a recombinant Rad53(573^730) fragment form a compact L-
sandwich consisting of 11 L-strands arranged in two antipar-
allel sheets and a short C-terminal K-helix.
The precise molecular function of the FHA domains in cell
cycle checkpoint kinases such as Dun1p and Rad53p will ul-
timately only be elucidated by the identi¢cation of speci¢c
binding proteins, and our de¢nition of the domain boundaries
should be helpful in this process.
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